Nutraceuticals Concerns Regarding Misinformation, Testing and Ingredients by bethjames

VIEWS: 49 PAGES: 2

More Info
									Compliance Insight, Inc.
FOR IMMEDIATE RELEASE

Contact:
Compliance-Insight1.com
513-860-3512
info@compliance-insight.com




   Nutraceuticals Concerns Regarding Misinformation, Testing and Ingredients

(Fairfield, Ohio) An increasing number of people are rejecting pharmaceutical drugs and surgery as
the only treatment to health problems, choosing preventive, supplementary, and alternative
natural foods and dietary supplements instead, reports Compliance Insight Inc.

The Dietary Supplement Health and Education Act (DSHEA), passed in 1994, removed dietary
supplements from the purview of the United States Food and Drug Administration (FDA) – a move
supported by the U.S. Congress and American consumers. The FDA guidelines for regulation of
pharmaceuticals are extremely strict. However,

Dietary supplements cannot be promoted for use as replacements for pharmaceuticals. Despite

However, the Act has led to confusion about the way nutraceuticals are packaged and advertised.
Subsequently, many professionals and consumers feel that there has been inadequate information
available about the quality and proper use of nutraceuticals and dietary supplements.

Healthcare professionals are turning to government-approved continuing medical education (CME)
distance learning programs and conferences to gain more information and knowledge about
nutraceuticals. These professionals have voiced concern about the relaxed monitoring of such
supplements and they feel that there is no quality check as nutraceuticals are based on natural
ingredients, which are generally imported. How these ingredients are grown and processed is not
known.

Doctors also feel that since there are no mandatory trials or studies conducted on the effect of
nutraceuticals, their health-improving benefits are questionable. They believe that there is a
possibility of manufacturers overstating the benefits of such products even though initial studies
have shown exciting results about the health-boosting effects of nutraceuticals and health
supplements.

There are concerns about specific ingredients used in nutraceutical products also. For example,
ephedrine is an ingredient used in several products; the FDA has specific limits on the use of
ephedrine and these specifications are not listed when the ingredient is used in nutraceuticals.
Consumers, on the other hand, may likely have several reasons for preferring nutraceuticals and
dietary supplements over traditional medications. The most important factor being the belief – as
compared to pharmaceutical drugs – that dietary supplements and nutraceuticals have fewer or no
side effects. But, as more doctors turn to prescribing such foods along with drugs, consumers want
to know if the doctor has a financial contract with the supplement manufacturer.

Manufacturers also fear misinformation about nutraceuticals might force unnecessary regulations
on the industry. The American Nutraceutical Association – which includes both consumers and
healthcare professionals – is now working closely with the FDA and industry trade organizations to
resolve such issues related to nutraceuticals and dietary supplements.
For more information visit http://compliance-insight1.com/

Compliance Insight, Inc. specializes in Regulatory and Quality Assurance consulting and training for
pharmaceutical, nutraceutical, medical device, chemical, and bio-technology companies in North
America, Europe and Asia.

For more information visit http://compliance-insight1.com/

								
To top